Goldman Sachs’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Goldman Sachs’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-15,500	Closed	-$1.56M	–	7573
2014 Q4	$1.56M	Buy	15,500 +3,400	+28%	+$264K	﹤0.01%	4111
2014 Q3	$803K	Buy	12,100 +400	+3%	+$26.3K	﹤0.01%	4824
2014 Q2	$817K	Sell	11,700 -2,000	-15%	-$136K	﹤0.01%	4885
2014 Q1	$1M	Sell	13,700 -104,100	-88%	-$7.76M	﹤0.01%	4672
2013 Q4	$8.11M	Buy	117,800 +60,300	+105%	+$3.9M	﹤0.01%	2560
2013 Q3	$3.65M	Sell	57,500 -57,500	-50%	-$3.48M	﹤0.01%	3283
2013 Q2	$5.55M	Buy	+115,000	New	+$5.65M	﹤0.01%	2622

Goldman Sachs's CBST Position: Q1 2015 in Review

Goldman Sachs sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 284,911 shares — an estimated $28.7M sold.

Goldman Sachs first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $35.8M in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Goldman Sachs reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Goldman Sachs sold 284,911 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $28.7M.
Goldman Sachs first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Goldman Sachs's CUBIST PHARMACEUTICALS INC position peaked at $35.8M in Q3 2013.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.